Abstract
Objectives
Study Design and Setting
Results
Conclusion
Keywords
- •Effective participation and group process is important to the functioning of guidelines and the development of impactful and evidence-based recommendations but tools to inform guideline development group members and panels are sparse.
- •This study presents the results of a mixed methods and iterative study to develop the Guideline Participant Tool (GPT) to support effective participation in guideline panels.
What this adds to what is known?
- •Guideline group members can be informed about their role and processes to optimize their participation in guideline development by using this tool.
- •The guideline participant tool gives suggestions to guideline participants for preparation, conduct during guideline group meetings, and in follow-up to guideline group meetings and can be used to improve the guideline process.
- •It informs the work performed to develop the GIN-McMaster Guideline Development Checklist and focuses on suggestions for the participants themselves.
- •We aim to include the findings in the new INGUIDE guideline development certification and credentialing program.
What is the implication and what should change now?
1. Background
Centro Nazionale per l’Eccellenza Clinica, la Qualità e la Sicurezza delle Cure - Istituto Superiore di Sanita. Manuale metodologico per la produzione di linee guida di pratica clinica. https://snlg.iss.it/wp-content/uploads/2019/04/MM_v1.3.2_apr_2019.pdf. Accessed November 30, 2019.
2. Methods
2.1 Guideline manual review

2.2 Qualitative interviews
2.3 External validation survey
3. Results
3.1 Guideline manual review results
- i.Conflict/declaration of interests, bias, confidentiality, and nondisclosure;
- ii.Decision-making processes;
- iii.Evaluation of guideline groups;
- iv.Facilitation tips, managing group conflict, and working with problematic participants;
- v.Follow-up from guideline group meetings;
- vi.Group processes recommendations;
- vii.Knowledge of participants in guideline groups;
- viii.Membership and participant qualities for guideline groups;
- ix.Preparations for guideline group meetings;
- x.Presentations to guideline groups;
- xi.Research and writing methods for participants;
- xii.Respect to fellow participants in the guideline group;
- xiii.Responsibilities and tasks of guideline group members;
- xiv.Timeline of participation in guideline groups; and
- xv.Training for prospective guideline group participants.
3.2 Interview results
Category | Characteristic | Number of interviews (%) |
---|---|---|
Guideline group member type | Guideline methodologist Content expert Sponsor organization Patient representative | 4 (40%) 4 (40%) 1 (10%) 1 (10%) |
Continent (of residence) | Europe Africa Americas Asia Australia and Pacific | 6 (60%) 1 (10%) 1 (10%) 1 (10%) 1 (10%) |
Gender | Male Female Other/prefer not to say | 6 (60%) 4 (40%) 0 (0%) |
Guideline experience | No prior experience Experience with 1 guideline More than 1 guideline | 2 (20%) 1 (10%) 7 (70%) |
3.2.1 Participant behavior
3.2.2 Selection of participants
3.2.3 Guideline group process
3.2.4 Format of the GPT
3.3 The tool
3.4 Validation survey results

4. Discussion
4.1 Strengths
4.2 Limitations
4.3 Implications for practice
4.4 Implications for research
5. Conclusions
CRediT authorship contribution statement
Acknowledgments
Supplementary data
- Data Profile
- Appendix 1
- Appendix 2
- Appendix 3
- Appendix 4
- Appendix 5
References
- Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations.Health Res Policy Syst. 2006; 4: 21
- Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.CMAJ. 2014; 186: E123-E142
- Methods for development of the European commission initiative on Breast cancer guidelines: recommendations in the era of guideline transparency.Ann Intern Med. 2019; 171: 273-280
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.Blood Adv. 2018; 2: 3226-3256
- Methodology for the development of the NHF-McMaster guideline on care models for haemophilia management.Haemophilia. 2016; 22: 17-22
Centro Nazionale per l’Eccellenza Clinica, la Qualità e la Sicurezza delle Cure - Istituto Superiore di Sanita. Manuale metodologico per la produzione di linee guida di pratica clinica. https://snlg.iss.it/wp-content/uploads/2019/04/MM_v1.3.2_apr_2019.pdf. Accessed November 30, 2019.
- GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.J Clin Epidemiol. 2017; 81: 101-110
- Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences.Blood Adv. 2020; 4: 2351-2365
- Improving the use of research evidence in guideline development: 5. Group processes.Health Res Policy Syst. 2006; 4: 17
- Developing and implementing guidelines for health policy and clinical practice in Estonia: interim appraisal of progress.in: World Health Organization Regional Office for Europe. World Health Organization, Kopenhagen2015
Article info
Publication history
Footnotes
Conflict of interest statement: HJS is on the steering group of and co-developed the INGUIDE program. The other authors have no interests to declare.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy